 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Combivir Users Warned About Label-Switching ReportsJune/July 2002 GlaxoSmithKline has received four reports of label switching on bottles of pills which should have contained Combivir, but actually contained Ziagen. Manufacturers are warning users of the medication Combivir to inspect their bottles and the tablets themselves prior to use. While both medications are used to treat HIV infection (and are combined in Trizivir), they have very different side effects. Ziagen side effects can include hypersensitivity, which in some instances can be fatal. Consumers with questions may call GlaxoSmithKline at (888) 825-5249.
Back to the June/July 2002 issue of Positive Living.
 This article was provided by AIDS Project Los Angeles. It is a part of the publication Positive Living. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
